The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBMPG.L Regulatory News (BMPG)

  • There is currently no data for BMPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

25 Jan 2022 07:00

RNS Number : 4388Z
BMO Managed Portfolio Trust PLC
25 January 2022
 

TO:

RNS

FROM:

BMO Managed Portfolio Trust PLC

DATE:

25 January 2022

LEI:

213800ZA6TW45NM9YY31

 

 

 

Unaudited Interim Results

The Board of BMO Managed Portfolio Trust PLC announces the unaudited interim results of the Company for the six month period to 30 November 2021.

 

Income Shares - Financial Highlights and Performance Summary for the Six Months

 

· Dividend yield(1) of 4.3% at 30 November 2021, compared to the yield on the FTSE All-Share Index of 3.2%. Dividends are paid quarterly and this year the aim is to make the payments of more equal amounts.

· Net asset value total return(1) per Income share of +1.7% for the six months underperforming the FTSE All-Share Index total return of +1.9% by -0.2%.

 

Growth Shares - Financial Highlights and Performance Summary for the Six Months

 

· Net asset value total return(1) per Growth share of +5.0% for the six months outperforming the FTSE All-Share Index total return of +1.9% by +3.1%.

· The net asset value per Growth share has increased by +214.0% over 10 years, the equivalent of +12.1% compound(1) per year. This has outperformed the FTSE All-Share Index total return of +103.0%, the equivalent of +7.3% compound per year.

 

Notes:

(1) Yield, total return and compound annual growth rate - See Alternative Performance Measures.

 

 

Chairman's Statement

 

Highlights

· Net asset value ("NAV") total return for the six months of +1.7% for the Income shares and +5.0% for the Growth shares as compared to the FTSE All-Share Index total return of +1.9%

· NAV total return compound annual growth rate over 10 years of +9.4% for the Income shares and +12.1% for the Growth shares compared with +7.3% from the FTSE All-Share Index

· Income share dividend yield of 4.3% at 30 November 2021

 

Investment Performance

For the six months to 30 November 2021, the NAV total return was +1.7% for the Income shares and +5.0% for the Growth shares. The total return for the benchmark index for both share classes, the FTSE All-Share Index, was +1.9%. The long-term track record continues to show the NAV total return for both share classes outperforming the benchmark index over 3 years, 5 years and 10 years to 30 November 2021, with the NAV total return over 10 years achieving a compound annual growth rate of +9.4% for the Income shares and +12.1% for the Growth shares compared with +7.3% from the benchmark index.

 

The period under review experienced a reversal of the trend that had been evident in financial markets since the announcement of the first vaccines for COVID-19 in November 2020. Equity markets, sectors and individual stocks that had been perceived to benefit from a re-opening of economies had recovered strongly. However, from the beginning of June 2021 this changed, and bond yields, which had been rising in anticipation of very robust economic growth, began to subside. Growth, though still strong, was less than expected. The UK equity market which had been one of the best performers amongst global markets began to lag, and sectors and stocks previously leading the recovery also started to underperform on a relative basis and stocks that had done well earlier in the pandemic resumed their trend of outperformance. These were led by the US technology sector; as an illustration the Nasdaq Composite Index gained 21.8% over the period.

 

This trend benefitted the Growth Portfolio, which outperformed the benchmark index over the

six months to 30 November 2021. A number of investment companies with exposure to the wider technology sector were the leading performers. This was led by the portfolio's largest holding Allianz Technology Trust which gained 30%. This was closely followed by HgCapital Trust ('HGT') which rose 27%. HGT is a private equity trust that specialises in business-critical software companies mainly based in Europe. Over the year to 30 September 2021, their top 20 holdings which account for over 80% of the assets of the trust grew earnings at 29% and revenues at 25%. The next best performer was another long-time holding, Scottish Mortgage Investment Trust, which experienced a 25% rise in its share price mainly as a result of its technology and healthcare holdings.

 

Due to the requirement for yield, it is always a challenge for the Income Portfolio to gain exposure to the secular growth opportunities offered by investment companies investing in the technology sector where the underlying companies pay no or low dividends. This was the main reason why the Income Portfolio was slightly behind the benchmark index over the six months to 30 November 2021. The leading performer and the largest holding was NB Private Equity Partners ('NBPE') whose share price gained 33%. NBPE is managed in the US where the majority of its portfolio is located. Most of its holdings are co-investments with other well known private equity managers like Blackstone and KKR. Recently its largest holding Autostore, which provides warehouse robot technology solutions for customers worldwide, was successfully listed on the Oslo Stock Exchange. NBPE pays a dividend equivalent to 3% of its NAV annually. The next best performer with a 14% rise in its share price was 3i Infrastructure. This has been one of the best performers in the Income Portfolio over the long term and also increased its dividend by 7% in its recent interim results.

 

(All share prices are total return).

 

Revenue and Dividends

The Company's net revenue return for the six months was £1.67 million which is equivalent to 3.54p per Income share (compared to 3.57p per Income share for the corresponding period in 2020). Income shareholders are entitled to all the dividends paid by the Company. One benefit of the closed-end investment trust structure is the ability to utilise revenue reserves, built up in previous years, to sustain dividend payments during periods when there is a significant reduction in dividend income from underlying holdings. That has been the case over the course of the COVID-19 pandemic and enabled many of our holdings to sustain or, in some cases, grow their dividend payments. Over recent months a number of holdings in the Income Portfolio have begun to announce increased dividend payments which is an encouraging sign of a return to health after the worst effects of the pandemic.

 

With the aim of making the quarterly interim dividends of more equal amounts, the rate for each of the first and second interim dividends in respect of the year to 31 May 2022 was increased to 1.55p per Income share (1.4p per Income share in the corresponding periods in the year to 31 May 2021).

 

In the absence of unforeseen circumstances, the Board intends to pay three quarterly interim dividends, each of 1.55p per Income share, and that the aggregate dividends for the current financial year to 31 May 2022 will be at least 6.2p per Income share (2021: 6.2p per Income share). As a result of making the interim dividends of more equal amounts and the increase in each of the first two interim dividends and the anticipated increase in the third interim dividend, the fourth interim dividend is expected to be lower than last year. The amount of the fourth interim dividend will be determined when a clearer view emerges of income for the year. A minimum expected annual rate of 6.2p per Income share represents a yield on the Income share price at 30 November 2021 of 4.3% which is materially higher than the yield of 3.2% on the FTSE All-Share Index at the same date.

 

Borrowing

At 30 November 2021 the Income Portfolio had total borrowings of £7 million (9.4% of gross assets), the investment of which helps to boost net income after allowing for the interest cost. The Growth Portfolio had no borrowings.

 

Management of Share Premium and Discount to NAV

In normal circumstances we aim to maintain the discount to NAV at which our shares trade at not more than 5%. In practice over the years the shares have generally traded close to NAV. During the six months to 30 November 2021 the average premium to NAV for the Income shares and for the Growth shares was 1.0% and 0.7% respectively. At 30 November 2021, the Income shares stood at a premium to NAV of 2.1% and the Growth shares at a premium of 1.4% to NAV.

 

Share Conversion Facility

Shareholders have the opportunity to convert their Income shares into Growth shares or their Growth shares into Income shares annually subject to minimum and maximum conversion thresholds which may be reduced or increased at the discretion of the Board. On 4 November 2021 the conversion proceeded for those shareholders who had elected to do so. The net result of those conversions was a decrease of 27,625 Income shares and an increase of 13,595 Growth shares in issue. The ability to convert without incurring capital gains tax should be an attractive facility for shareholders and the next conversion date (subject to minimum and maximum thresholds) will be in October 2022. Details will be provided when the Company's annual report is published in late July 2022.

 

Board Changes

Following the Annual General Meeting on 30 September 2021, the Chairman Colin McGill retired from the Board and I was pleased to accept the Board's invitation to become Chairman. Colin was a director of your Company for over 13 years since its launch in 2008 and served as Chairman of the Audit Committee until January 2019 at which point he was appointed Chairman of the Board. I would like to thank Colin for his exceptional contribution and commitment to the Company throughout this time.

 

Following Colin's retirement I have also become Chairman of the Management Engagement Committee and Nomination Committee. As noted in the last Annual Report, David Harris was also appointed as a director at the launch of the Company in 2008 and has now served on the Board for close to 14 years. It is anticipated that David will retire at the AGM in September 2022 and a recruitment process to identify a new non-executive director will be undertaken in the first half of 2022.

 

Ownership of the Manager

On 8 November 2021, Columbia Threadneedle Investments, part of Ameriprise Financial, acquired BMO's EMEA asset management business ('BMO GAM (EMEA)'). This added £97 billion of assets under management ('AUM') to Columbia Threadneedle increasing its AUM to £530 billion. This was a transaction that was discussed in the Chairman's Statement in respect of the year to 31 May 2021. Your Board maintained a regular dialogue with BMO and has met with the CEO of Columbia Threadneedle Investments. We look forward to benefitting from the increase in scale and resources that the combined BMO/Columbia Threadneedle business can provide, and we are assured there will be no changes to the personnel running the activities of your Company in terms of both Fund Management and Administration.

 

Outlook

As Governments and Central Banks acknowledge that inflation has moved from being "transitory" to "sustained", this has reflected in a tapering down of monetary stimulus and the start (albeit from very low levels) of increases in interest rates. The Bank of England increased UK rates in December. The key theme in 2022 will be the speed and magnitude of interest rate rises and the chances of a policy mistake have increased.

 

For equity markets, volatility will likely increase and against a background of higher inflation and rising interest rates, positive equity returns may be harder to achieve. One of the features of the past decade has been the superior level of corporate earnings growth in the US, almost entirely due to the technology sector. In particular, the Growth Portfolio has benefitted from a number of investment companies with significant exposure in this area. Although earnings growth will remain strong from the US, the high valuations accorded to many companies in the technology sector may come under pressure in an environment when inflation is higher and interest rates start to rise. As economies continue to recover, the ability to grow earnings may not be so scarce and investors may begin to question the extent of the valuation premium of "growth" companies. At a market level this favours non-US equities, with European stock markets well placed, as is the UK stock market which is the most lowly valued.

 

In terms of investment strategy, the aim is to continue increasing exposure to UK equity trusts, especially those with a medium and smaller company bias, and also certain trusts with a decent exposure to Europe. This would be funded by some reduction in investment companies with significant exposure to technology and/or high growth companies.

 

 

David Warnock

Chairman

24 January 2022

 

 

Unaudited Condensed Income Statement

Six months to 30 November 2021

 

 

 

 

 

 

 

 

 

Notes

Revenue

Capital

Total

 

 

£'000

£'000

£'000

Gains on investments

 

-

5,364

5,364

Foreign exchange losses

 

-

(2)

(2)

Income

2

2,178

-

2,178

Investment management and performance fees

3

(171)

(675)

(846)

Other expenses

 

(307)

-

(307)

Return on ordinary activities before

finance costs and tax

 

 

1,700

 

4,687

 

6,387

Finance costs

 

(28)

(42)

(70)

Return on ordinary activities before tax

 

1,672

4,645

6,317

Tax on ordinary activities

 

-

-

-

Return attributable to shareholders

 

1,672

4,645

6,317

Return per Income share (pence)

4

3.54p

(1.23p)

2.31p

Return per Growth share (pence)

4

-

13.75p

13.75p

 

 

 

 

 

      

 

The total column of this statement is the Profit and Loss Account of the Company. The supplementary revenue and capital columns are prepared under guidance published by The Association of Investment Companies.

 

All revenue and capital items in the Income Statement derive from continuing operations.

 

Return attributable to shareholders represents the profit/(loss) for the period and also total comprehensive income.

 

Unaudited Condensed Income Statement

Six months to 30 November 2020

 

 

Notes

Revenue

Capital

Total

 

 

£'000

£'000

£'000

Gains on investments

 

-

20,873

20,873

Foreign exchange losses

 

-

(13)

(13)

Income

2

2,109

-

2,109

Investment management and performance fees

3

(138)

(619)

(757)

Other expenses

 

(281)

-

(281)

Return on ordinary activities before

finance costs and tax

 

 

1,690

 

20,241

 

21,931

Finance costs

 

(22)

(33)

(55)

Return on ordinary activities before tax

 

1,668

20,208

21,876

Tax on ordinary activities

 

-

-

-

Return attributable to shareholders

 

1,668

20,208

21,876

Return per Income share (pence)

4

3.57p

11.12p

14.69p

Return per Growth share (pence)

4

-

41.58p

41.58p

 

The total column of this statement is the Profit and Loss Account of the Company. The supplementary revenue and capital columns are prepared under guidance published by The Association of Investment Companies.

 

All revenue and capital items in the Income Statement derive from continuing operations.

 

Return attributable to shareholders represents the profit/(loss) for the period and also total comprehensive income.

 

 

Condensed Income Statement (audited)

Year to 31 May 2021

 

 

 

 

 

 

 

 

 

Notes

Revenue

Capital

Total

 

 

£'000

£'000

£'000

 

 

 

 

 

Gains on investments

 

-

38,132

38,132

Foreign exchange losses

 

-

(17)

(17)

Income

2

4,022

-

4,022

Investment management and performance fees

3

(290)

(1,360)

(1,650)

Other expenses

 

(589)

-

(589)

Return on ordinary activities before

finance costs and tax

 

 

3,143

 

36,755

 

39,898

 

Finance costs

 

(47)

(69)

(116)

 

 

 

 

 

Return on ordinary activities before tax

 

3,096

36,686

39,782

Tax on ordinary activities

 

(16)

-

(16)

Return attributable to shareholders

 

3,080

36,686

39,766

Return per Income share (pence)

4

6.59p

25.94p

32.53p

Return per Growth share (pence)

4

-

67.27p

67.27p

      

 

 

 

The total column of this statement is the Profit and Loss Account of the Company. The supplementary revenue and capital columns are prepared under guidance published by The Association of Investment Companies.

 

All revenue and capital items in the Income Statement derive from continuing activities.

 

Return attributable to shareholders represents the profit/(loss) for the year and also total comprehensive income.

 

 

Unaudited Condensed Balance Sheet

As at 30 November 2021

 

 

 

 

Notes

Income

Shares

Growth

Shares

 

Total

 

 

£'000

£'000

£'000

Fixed assets

 

 

 

 

Listed investments

6

72,215

105,604

177,819

 

 

 

 

 

Current assets

 

 

 

 

Debtors

 

380

63

443

Cash at bank and on deposit

 

2,053

5,847

7,900

 

 

 

 

 

 

 

2,433

5,910

8,343

 

 

 

 

 

Creditors:

Amounts falling due within one year

 

7

 

(7,230)

 

(996)

 

(8,226)

 

 

 

 

 

Net current (liabilities)/assets

 

(4,797)

4,914

117

 

 

 

 

 

Creditors:

Amounts falling due in more than one year

 

 

 

-

 

-

 

-

 

 

 

 

 

Net assets

 

67,418

110,518

177,936

 

 

 

 

 

Capital and reserves:

 

 

 

 

Called-up share capital

8

4,540

3,622

8,162

Share premium

 

28,793

27,594

56,387

Capital redemption reserve

 

256

365

621

Special reserve

 

18,980

17,199

36,179

Capital reserves

 

11,794

61,738

73,532

Revenue reserve

 

3,055

-

3,055

 

 

 

 

 

Shareholders' funds

 

67,418

110,518

117,936

 

 

 

 

 

Net asset value per share (pence)

9

141.07p

289.81p

 

 

 

 

Unaudited Condensed Balance Sheet

As at 30 November 2020

 

 

 

Notes

Income

Shares

Growth

Shares

 

Total

 

 

£'000

£'000

£'000

Fixed assets

 

 

 

 

Listed investments

 

63,466

88,159

151,625

 

 

 

 

 

Current assets

 

 

 

 

Debtors

 

230

77

307

Cash at bank and on deposit

 

1,237

3,127

4,364

 

 

 

 

 

 

 

1,467

3,204

4,671

 

 

 

 

 

Creditors:

Amounts falling due within one year

 

7

 

(491)

 

(393)

 

(884)

 

 

 

 

 

Net current assets

 

976

2,811

3,787

 

 

 

 

 

Creditors:

Amounts falling due in more than one year

 

 

 

(5,000)

 

-

 

(5,000)

 

 

 

 

 

Net assets

 

59,442

90,970

150,412

 

 

 

 

 

Capital and reserves:

 

 

 

 

Called-up share capital

 

4,446

3,458

7,904

Share premium

 

27,359

23,019

50,378

Capital redemption reserve

 

252

364

616

Special reserve

 

18,990

17,162

36,152

Capital reserves

 

5,442

46,967

52,409

Revenue reserve

 

2,953

-

2,953

 

 

 

 

 

Shareholders' funds

 

59,442

90,970

150,412

 

 

 

 

 

Net asset value per share (pence)

9

127.16p

249.94p

 

 

 

Condensed Balance Sheet (audited)

As at 31 May 2021

 

 

Notes

Income shares

Growth shares

 

Total

 

 

£'000

£'000

£'000

 

 

 

 

 

Fixed assets

 

 

 

 

Listed investments

6

72,121

101,052

173,173

 

Current assets

 

 

 

 

Debtors

 

272

54

326

Cash at bank and on deposit

 

2,040

3,769

5,809

 

 

 

 

 

 

 

2,312

3,823

6,135

Creditors

 

 

 

 

Amounts falling due within one year

7

(7,667)

(649)

(8,316)

 

 

 

 

 

Net current (liabilities)/assets

 

(5,355)

3,174

(2,181)

 

 

 

 

 

Creditors:

 

 

 

 

Amounts falling due in more than one year

 

-

-

-

 

 

 

 

 

Net assets

 

66,766

104,226

170,992

 

 

 

 

 

Capital and reserves

 

 

 

 

Called-up share capital

8

4,459

3,586

8,045

Share premium

 

27,608

26,599

54,207

Capital redemption reserve

 

256

365

621

Special reserve

 

19,017

17,162

36,179

Capital reserves

 

12,373

56,514

68,887

Revenue reserve

 

3,053

-

3,053

 

 

 

 

 

Shareholders' Funds

 

66,766

104,226

170,992

 

 

 

 

 

Net asset value per share (pence)

9

142.22p

276.01p

 

 

 

Unaudited Condensed Statement of Cash Flows

Six months to 30 November 2021

 

 

 

Notes

Income shares

Growth shares

 

Total

 

 

£'000

£'000

£'000

 

 

 

 

 

Net cash outflow from operations before dividends

and interest

 

 10

 

(841)

 

(921)

 

(1,762)

Dividends received

 

1,540

573

2,113

Interest received

 

-

-

-

Interest paid

 

(59)

-

(59)

Net cash inflow/(outflow) from operating activities

 

640

(348)

292

Investing activities

 

 

 

 

Purchases of investments

 

(1,620)

(2,120)

(3,740)

Sales of investments

 

1,506

3,478

4,984

Cash flows from investing activities

 

(114)

1,358

1,244

Cash flows before financing activities

 

526

1,010

1,536

Financing activities

 

 

 

 

Equity dividends paid

Net proceeds from issuance of new shares

5

(1,670)

1,196

-

1,029

(1,670)

2,225

Share conversion

 

(39)

39

-

Cash flows from financing activities

 

(513)

1,068

555

Net movement in cash and cash equivalents

 

13

2,078

2,091

 

Cash and cash equivalents at the beginning of the period

 

 

2,040

 

3,769

 

5,809

 

Cash and cash equivalents at the end of the period

 

 

2,053

 

5,847

 

7,900

Represented by:

Cash at bank and short-term deposits

 

 

2,053

 

5,847

 

7,900

 

Unaudited Condensed Statement of Cash Flows

Six months to 30 November 2020

 

 

 

Notes

Income shares

Growth shares

 

Total

 

 

£'000

£'000

£'000

 

 

 

 

 

Net cash outflow from operations before dividends

and interest

 

 10

 

(277)

 

(942)

 

(1,219)

Dividends received

 

1,519

531

2,050

Interest received

 

-

-

-

Interest paid

 

(52)

-

(52)

Net cash inflow/(outflow) from operating activities

 

1,190

(411)

779

Investing activities

 

 

 

 

Purchases of investments

 

(1,327)

(2,777)

(4,104)

Sales of investments

 

1,529

2,053

3,582

Cash flows from investing activities

 

202

(724)

(522)

Cash flows before financing activities

 

1,392

(1,135)

257

Financing activities

 

 

 

 

Equity dividends paid

Net proceeds from issuance of new shares

5

(1,540)

488

-

1,056

(1,540)

1,544

Shares purchased to be held in treasury

 

(29)

-

(29)

Share conversion

 

(135)

135

-

Cash flows from financing activities

 

(1,216)

1,191

(25)

Net movement in cash and cash equivalents

 

176

56

232

 

Cash and cash equivalents at the beginning of the period

 

 

1,061

 

3,071

 

4,132

 

Cash and cash equivalents at the end of the period

 

 

1,237

 

3,127

 

4,364

Represented by:

Cash at bank and short-term deposits

 

 

1,237

 

3,127

 

4,364

 

 

 

 

 

Condensed Statement of Cash Flows (audited)

Year to 31 May 2021

 

 

 

 

 

Notes

Income shares

Growth shares

 

Total

 

 

£'000

£'000

£'000

 

 

 

 

 

Net cash outflow from operations before dividends

and interest

 

  10

 

(606)

 

(1,413)

 

(2,019)

Dividends received

 

2,891

1,072

3,963

Interest received

 

1

-

1

Interest paid

 

(118)

-

(118)

Net cash inflow/(outflow) from operating activities

 

2,168

(341)

1,827

Investing activities

 

 

 

 

Purchases of investments

 

(4,363)

(8,174)

(12,537)

Sales of investments

 

3,409

4,313

7,722

Cash flows from investing activities

 

(954)

(3,861)

(4,815)

Cash flows before financing activities

 

1,214

(4,202)

(2,988)

Financing activities

 

 

 

 

Equity dividends paid

5

(2,852)

-

(2,852)

Net proceeds from issue of new shares

Sale of shares from treasury

 

710

599

4,765

-

5,475

599

Shares purchased to be held in treasury

 

(557)

-

(557)

Share conversion

 

(135)

135

-

Loan drawn down

 

2,000

-

2,000

Cash flows from financing activities

 

(235)

4,900

4,665

Net movement in cash and cash equivalents

 

979

698

1,677

 

Cash and cash equivalents at the beginning of the year

 

 

1,061

 

3,071

 

4,132

 

Cash and cash equivalents at the end of the year

 

 

2,040

 

3,769

 

5,809

Represented by:

Cash at bank and short-term deposits

 

 

2,040

 

3,769

 

5,809

      

 

 

 

Unaudited Condensed Statement of Changes in Equity

Six months to 30 November 2021

 

 

 

 

Income shares

 

Share capital

£000

Share premium account

£000

Capital redemption reserve

£000

 

Special reserve

£000

 

Capital reserves

£000

 

Revenue reserve

£000

Total shareholders' funds

£000

As at 31 May 2021

4,459

27,608

256

19,017

12,373

3,053

66,766

Increase in share capital in issue, net of share issuance expenses

 

 

 

83

 

 

 

1,185

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,268

Share conversion

(2)

-

-

(37)

-

-

(39)

Transfer of net income from Growth to Income portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

327

 

 

327

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(327)

 

 

-

 

 

(327)

Dividends paid

-

-

-

-

-

(1,670)

(1,670)

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

(252)

 

1,345

 

1,093

As at 30 November 2021

 

4,540

 

28,793

 

256

 

18,980

 

11,794

 

3,055

 

67,418

 

 

 

 

 

 

 

 

Growth shares

 

 

 

 

 

 

 

As at 31 May 2021

3,586

26,599

365

17,162

56,514

-

104,226

Increase in share capital in issue, net of issuance expenses

 

 

34

 

 

995

 

 

-

 

 

-

 

 

-

 

 

-

 

 

1,029

Share conversion

2

-

-

37

-

-

39

Transfer of net income from Growth to Income portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(327)

 

 

(327)

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

327

 

 

-

 

 

327

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

4,897

 

327

 

5,224

As at 30 November 2021

 

3,622

 

27,594

 

365

 

17,199

 

61,738

 

-

 

110,518

 

Total

 

 

 

 

 

 

 

As at 31 May 2021

8,045

54,207

621

36,179

68,887

3,053

170,992

Increase in share capital in issue, net of share issuance expenses

 

 

 

117

 

 

 

2,180

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,297

Share conversion

-

-

-

-

-

-

-

Dividends paid

-

-

-

-

-

(1,670)

(1,670)

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

4,645

 

1,672

 

6,317

Total Company as at 30 November 2021

 

8,162

 

56,387

 

621

 

36,179

 

73,532

 

3,055

 

177,936

 

Unaudited Condensed Statement of Changes in Equity

Six months to 30 November 2020

 

 

 

 

 

Income shares

 

Share capital

£000

Share premium account

£000

Capital redemption reserve

£000

 

Special reserve

£000

 

Capital reserves

£000

 

Revenue reserve

£000

Total shareholders' funds

£000

As at 31 May 2020

4,415

26,909

252

19,147

240

2,825

53,788

Increase in share capital in issue, net of share issuance expenses

 

 

 

38

 

 

 

450

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

488

Shares purchased for treasury

 

-

 

-

 

-

 

(29)

 

-

 

-

 

(29)

Share conversion

(7)

-

-

(128)

-

-

(135)

Transfer of net income from Growth to Income portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

310

 

 

310

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(310)

 

 

-

 

 

(310)

Dividends paid

-

-

-

-

-

(1,540)

(1,540)

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

5,512

 

1,358

 

6,870

As at 30 November 2020

 

4,446

 

27,359

 

252

 

18,990

 

5,442

 

2,953

 

59,442

 

 

 

 

 

 

 

 

Growth shares

 

 

 

 

 

 

 

As at 31 May 2020

3,408

22,006

364

17,034

31,961

-

74,773

Increase in share capital in issue, net of issuance expenses

 

 

43

 

 

1,013

 

 

-

 

 

-

 

 

-

 

 

-

 

 

1,056

Share conversion

7

-

-

128

-

-

135

Transfer of net income from Growth to Income portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(310)

 

 

(310)

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

310

 

 

-

 

 

310

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

14,696

 

310

 

15,006

As at 30 November 2020

 

3,458

 

23,019

 

364

 

17,162

 

46,967

 

-

 

90,970

 

Total

 

 

 

 

 

 

 

As at 31 May 2020

7,823

48,915

616

36,181

32,201

2,825

128,561

Increase in share capital in issue, net of share issuance expenses

 

 

 

81

 

 

 

1,463

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,544

Shares purchased for treasury

 

-

 

-

 

-

 

(29)

 

-

 

-

 

(29)

Share conversion

-

-

-

-

-

-

-

Dividends paid

-

-

-

-

-

(1,540)

(1,540)

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

20,208

 

1,668

 

21,876

Total Company as at 30 November 2020

 

7,904

 

50,378

 

616

 

36,152

 

52,409

 

2,953

 

150,412

 

Condensed Statement of Changes in Equity (audited)

Year to 31 May 2021

 

 

 

 

Income Shares

 

Share capital

£000

Share premium account

£000

Capital redemption reserve

£000

 

Special reserve

£000

 

Capital reserves

£000

 

Revenue reserve

£000

Total shareholders' funds

£000

As at 31 May 2020

4,415

26,909

252

19,147

240

2,825

53,788

Increase in share capital in issue, net of share issuance expenses

 

 

55

 

 

655

 

 

-

 

 

-

 

 

-

 

 

-

 

 

710

Shares sold from treasury

-

44

-

555

-

-

599

Shares purchased for treasury

 

-

 

-

 

-

 

(557)

 

-

 

-

 

(557)

Share conversion

(7)

-

-

(128)

-

-

(135)

Cancellation of deferred shares

 

(4)

 

-

 

4

 

-

 

-

 

-

 

-

Transfer of net income from Growth to Income portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

564

 

 

564

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(564)

 

 

-

 

 

(564)

Dividends paid

-

-

-

-

-

(2,852)

(2,852)

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

12,697

 

2,516

 

15,213

As at 31 May 2021

4,459

27,608

256

19,017

12,373

3,053

66,766

Growth Shares

 

 

 

 

 

 

 

As at 31 May 2020

3,408

22,006

364

17,034

31,961

-

74,773

Increase in share capital in issue, net of share issuance expenses

 

 

172

 

 

4,593

 

 

-

 

 

-

 

 

-

 

 

-

 

 

4,765

Share conversion

7

-

-

128

-

-

135

Cancellation of deferred shares

 

(1)

 

-

 

1

 

-

 

-

 

-

 

-

Transfer of net income from Growth to Income portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(564)

 

 

(564)

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

564

 

 

-

 

 

564

Return attributable to shareholders

-

-

-

-

23,989

564

24,553

As at 31 May 2021

3,586

26,599

365

17,162

56,514

-

104,226

Total

 

 

 

 

 

 

 

As at 31 May 2020

7,823

48,915

616

36,181

32,201

2,825

128,561

Increase in share capital in issue, net of share issuance expenses

 

 

227

 

 

5,248

 

 

-

 

 

-

 

 

-

 

 

-

 

 

5,475

Shares sold from treasury

 

-

 

44

 

-

 

555

 

-

 

-

 

599

Shares purchased for treasury

 

-

 

-

 

-

 

(557)

 

-

 

-

 

(557)

Share conversion

-

-

-

-

-

-

-

Cancellation of deferred shares

 

(5)

 

-

 

5

 

-

 

-

 

-

 

-

Dividends paid

-

-

-

-

-

(2,852)

(2,852)

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

36,686

 

3,080

 

39,766

Total Company as at 31 May 2021

8,045

54,207

621

36,179

68,887

3,053

170,992

 

Notes

 

1. Accounting policies

These condensed financial statements, which are unaudited, have been prepared on a going concern basis in accordance with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, FRS 102, FRS 104 Interim Financial Reporting and the Statement of Recommended Practice ("SORP") "Financial Statements of Investment Trust Companies and Venture Capital Trusts" issued by The Association of Investment Companies ("AIC").

 

The accounting policies applied for the condensed financial statements are set out in the Company's annual report for the year ended 31 May 2021.

 

2. Income

 

Six months to

30 November 2021

Six months to

30 November 2020

Year to

31 May

2021

 

£'000

£'000

£'000

UK dividends

1,738

1,579

2,772

Overseas dividends

440

530

1,249

Deposit income

-

-

1

Total income

2,178

2,109

4,022

 

3. Investment management and performance fees

 

 

Six months to

30 November 2021

Six months to

30 November 2020

Year to

31 May

2021

 

£'000

£'000

£'000

Investment management fee

609

483

1,025

Performance fee

237

274

625

 

846

757

1,650

 

At 30 November 2021 the adjusted total return of the Income portfolio for the period since 31 May 2021 (being the date a performance fee was last payable and including the outperformance brought forward in excess of the cap of 0.35% of total assets at 31 May 2021) exceeded that of the FTSE All-Share Index and a performance fee of £42,000 was accrued in the Income portfolio (30 November 2020: £114,000; 31 May 2021: £259,000).

 

At 30 November 2021 the adjusted total return of the Growth portfolio for the period since 31 May 2021 (being the date a performance fee was last payable and including the outperformance brought forward in excess of the cap of 0.35% of total assets at 31 May 2021) exceeded that of the FTSE All-Share Index and a performance fee of £1,473,000 has been calculated (30 November 2020: £1,695,000; 31 May 2021: £1,471,000). However, as the performance fee is capped at 0.35% of total assets of the relevant portfolio, the fee has been scaled back, in line with the cap, and an amount of £195,000 (30 November 2020: £160,000; 31 May 2021: £366,000) has been recognised.

 

 

 

4. Return per share

 

The return per share for the six months to 30 November 2021 is as follows:

 

 

Income shares

Growth shares

 

Revenue

Capital

Total

Revenue

Capital

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

Return attributable to portfolios

 

1,345

 

(252)

 

1,093

 

327

 

4,897

 

5,224

Transfer of net income from Growth to Income portfolio

 

 

327

 

 

-

 

 

327

 

 

(327)

 

 

-

 

 

(327)

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

(327)

 

 

(327)

 

 

-

 

 

327

 

 

327

 Return attributable to shareholders

 

1,672

 

(579)

 

1,093

 

-

 

5,224

 

5,224

Return per share

3.54p

(1.23p)

2.31p

-

13.75p

13.75p

Weighted average number of shares in issue during the period

 

 

47,256,712

 

 

37,999,706

 

 

The return per share for the comparative six months to 30 November 2020 is as follows:

 

 

 

Income shares

Growth shares

 

Revenue

Capital

Total

Revenue

Capital

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

Return attributable to portfolios

 

1,358

 

5,512

 

6,870

 

310

 

14,696

 

15,006

Transfer of net income from Growth to Income portfolio

 

 

310

 

 

-

 

 

310

 

 

(310)

 

 

-

 

 

(310)

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

(310)

 

 

(310)

 

 

-

 

 

310

 

 

310

Return attributable to shareholders

 

1,668

 

5,202

 

6,870

 

-

 

15,006

 

15,006

Return per share

3.57p

11.12p

14.69p

-

41.58p

41.58p

Weighted average number of shares in issue during the period

 

 

46,766,360

 

 

36,089,942

 

 

 

The return per share for the comparative year to 31 May 2021 is as follows:

 

 

Income shares

Growth shares

 

Revenue

Capital

Total

Revenue

Capital

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

Return attributable to portfolios

 

2,516

 

12,697

 

15,213

 

564

 

23,989

 

24,553

Transfer of net income from Growth to Income portfolio

 

 

564

 

 

-

 

 

564

 

 

(564)

 

 

-

 

 

(564)

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

(564)

 

 

(564)

 

 

-

 

 

564

 

 

564

 Return attributable to shareholders

 

3,080

 

12,133

 

15,213

 

-

 

24,553

 

24,553

Return per share

6.59p

25.94p

32.53p

-

67.27p

67.27p

Weighted average number of shares in issue during the period

 

 

46,772,385

 

 

36,497,458

 

 

5. Dividends

 

 

 

 

 

Payment

Six months to

30 November

2021

Six months to

30 November

2020

Year to

31 May

2021

Dividends on Income shares

Date

£'000

£'000

£'000

Amounts recognised as distributions during the period:

 

 

 

 

 

In respect of the previous financial year:

 

 

 

 

 - fourth interim of 2.0p (prior period: 1.9p) per share

 

9-Jul-2021

 

939

 

883

 

883

In respect of the period under review:

 

 

 

 

- first interim of 1.55p (prior period: 1.4p) per share

 

8-Oct-2021

 

731

 

657

 

657

- second interim (prior period: 1.4p per share)

 

-

 

-

 

-

 

655

- third interim (prior period: 1.4p per share)

 

-

 

-

 

-

 

657

 

 

1,670

1,540

2,852

 

A second interim dividend in respect of the year to 31 May 2022 of 1.55p per Income share was paid on 7 January 2022 to shareholders on the register on 17 December 2021. This amount has not been accrued in the results for the six months to 30 November 2021.

 

For the financial year to 31 May 2021 interim dividends totalled 6.2p per Income share.

 

The Growth shares do not carry an entitlement to receive dividends.

 

 

 

6. Investments

 

 

Income shares

Level 1*

£'000

Growth shares

Level 1*

£'000

 

 

Total

£'000

Cost at 31 May 2021

Gains at 31 May 2021

52,669

19,452

51,601

49,451

104,270

68,903

Valuation at 31 May 2021

Movement in the period:

Purchases at cost

Sales proceeds

(Losses)/gains on investments sold in the period

Gains on investments held at period end

72,121

 

1,618

(1,506)

(252)

234

101,052

 

2,648

(3,478)

1,942

3,440

173,173

 

4,266

(4,984)

1,690

3,674

Valuation of investments held at 30 November 2021

 

72,215

 

105,604

 

177,819

 

 

 

Income shares

Level 1*

£'000

Growth shares

Level 1*

£'000

 

 

Total

£'000

Cost at 30 November 2021

Gains at 30 November 2021

52,529

19,686

52,713

52,891

105,242

72,577

Valuation at 30 November 2021

72,215

105,604

177,819

 

* Fair value hierarchy

 

 

 

Total (losses)/gains on investments

Income shares

£'000

Growth shares

£'000

 

Total

£'000

(Losses)/gains on investments sold in the period

Gains on investments held at period end

(252)

234

1,942

3,440

1,690

3,674

Total (losses)/gains on investments

(18)

5,382

5,364

 

The Company's Investments as disclosed in the balance sheet are valued at fair value. The fair value as at the reporting date has been estimated using the following fair value hierachy:

 

· Level 1 - quoted prices (unadjusted) in active markets for identical assets;

· Level 2 - investments whose value is evidenced by comparison with other observable current market transactions in the same instrument or based on a valuation technique whose variables includes only data from observable markets; and

· Level 3 - investments whose value is not based on observable market data.

 

There were no investments held which are valued in accordance with Levels 2 or 3.

 

 

 

7. Creditors

Amounts falling due within one year

 

 

 

30 November 2021

 

Income shares

£'000

 

 Growth shares

£'000

 

Total

£'000

£5 million fixed rate term loan maturing

10 February 2022

 

5,000

 

-

 

5,000

Revolving credit facility

2,000

-

2,000

Management fee accrued

124

182

306

Performance fee provision

42

195

237

Secretarial fee accrued

10

16

26

Amount due to brokers

-

528

528

Other accruals

54

75

129

 

7,230

996

8,226

     

 

 

 

30 November 2020

 

Income shares

£'000

 

 Growth shares

£'000

 

Total

£'000

Management fee accrued

105

145

250

Performance fee provision

320

160

480

Secretarial fee accrued

11

15

26

Other accruals

55

73

128

 

491

393

884

 

 

31 May 2021

 

Income shares

£'000

 

 Growth shares

£'000

 

Total

£'000

£5 million fixed rate term loan maturing

10 February 2022

 

5,000

 

-

 

5,000

Revolving credit facility

2,000

-

2,000

Management fee accrued

119

169

288

Performance fee accrued

465

366

831

Secretarial fee accrued

10

15

25

Other accruals

73

99

172

 

7,667

649

8,316

 

The Company has a £5 million unsecured fixed rate term loan and a £5 million unsecured revolving credit facility with The Royal Bank of Scotland International Limited. The fixed rate term loan and the unsecured revolving credit facility are available until 10 February 2022. £5 million of the fixed rate term loan was drawn down as at 30 November 2021 (30 November 2020: £5 million; 31 May 2021: £5 million) and the interest rate on the amount drawn down is fixed at 2.03% per annum. £2 million of the unsecured revolving credit facility was drawn down as at 30 November 2021 (30 November 2020: nil; 31 May 2021: £2 million). The interest rate on the amounts drawn down are variable, and a non-utilisation fee is payable on undrawn amounts.

During the six months to 30 November 2021 there were no changes in the amount borrowed and therefore no change in liabilities arising from financing activities.

 

 

 

 

8. Share capital

 

 

Listed

Held in treasury

In issue

 

Number

£'000

Number

£'000

Number

£'000

Income shares

 

 

 

 

 

 

 

Balance at 1 June 2021^

 

46,944,790

 

4,459

 

-

 

-

 

46,944,790

 

4,459

Issued

875,000

83

-

-

875,000

83

 Share conversion:

 

 

 

 

 

 

- Income to Growth

(150,027)

(15)

-

-

(150,027)

(15)

- Growth to Income

122,402

12

-

-

122,402

12

Balance at 30 November 2021^

47,792,165

4,539

-

-

47,792,165

4,539

 

 

Deferred shares -

Income

 

 

 

Number

£'000

 

 

 

 

Deferred shares - Income

 

 

 

 

 

 

Balance at 1 June 2021

-

-

 

 

 

 

Issue of 150,027 shares*

150,027

1

 

 

 

 

Balance at 30 November 2021

150,027

1

 

 

 

 

Total called-up share capital

 

4,540

 

 

 

 

 

^ The nominal value of each Income share is £0.094976101 per Income share.

* The nominal value of a Deferred share is £0.006337311 per share.

 

During the period, the Company issued 875,000 Income shares (30 November 2020: 400,000; 31 May 2021: 575,000) from the block listing facilities receiving net proceeds of £1,268,000

(30 November 2020: £488,000; 31 May 2021: £710,000).

 

During the period, valid conversion notices were received to convert 150,027 Income shares (which represented a value of £212,000). These were converted into 73,833 Growth shares in accordance with the Company's Articles and by reference to the ratio of the relative underlying net asset values of the Growth shares and Income shares on the conversion date.

 

The Company's Articles allow for Deferred shares to be allotted as part of the share conversion to ensure that the conversion does not result in a reduction of the aggregate par value of the Company's issued share capital. The Deferred shares issued as part of the share conversion in the current period are set out above. The Deferred shares will be repurchased by the Company from time to time as authorised by shareholders at the September 2021 AGM.

 

 

 

 

 

Listed

Held in treasury

In issue

 

Number

£'000

Number

£'000

Number

£'000

Growth shares

 

 

 

 

 

 

Balance at 1 June 2021^

37,761,553

3,586

-

-

37,761,553

3,586

Issued

360,000

34

-

-

360,000

34

Share conversion:

 

 

 

 

 

 

- Growth to Income

(60,238)

(5)

-

-

(60,238)

(5)

- Income to Growth

73,833

7

-

-

73,833

7

Balance at

30 November 2021^

 

38,135,148

 

3,622

 

-

 

-

 

38,135,148

 

3,622

 

 

Deferred shares -

 

 

 

 

Growth

 

 

 

 

 

Number

£'000

 

 

 

 

Deferred shares - Growth

 

 

 

 

 

 

Balance at 1 June 2021

-

-

 

 

 

 

Issue of 60,238 shares*

60,238

-

 

 

 

 

Balance at 30 November 2021

60,238

-

 

 

 

 

Total called-up share capital

 

3,622

 

 

 

 

 

^ The nominal value of each Growth share is £0.094976101 per Growth share.

* The nominal value of a Deferred share is £0.006337311 per share.

 

During the period, the Company issued 360,000 Growth shares (30 November 2020: 450,000; 31 May 2021: 1,815,000) from the block listing facilities receiving net proceeds of £1,029,000

(30 November 2020: £1,056,000; 31 May 2021: £4,765,000).

 

During the period, valid conversions were received to convert 60,238 Growth shares (which represented a value of £173,000). These were converted into 122,402 Income shares in accordance with the Company's Articles and by reference to the ratio of the relative underlying net asset values of the Growth shares and Income shares on the conversion date.

 

The Company's Articles allow for Deferred shares to be allotted as part of the share conversion to ensure that the conversion does not result in a reduction of the aggregate par value of the Company's issued share capital. The Deferred shares issued as part of the share conversion in the current period are set out above. The Deferred shares will be repurchased by the Company from time to time as authorised by shareholders at the September 2021 AGM.

 

 

9. Net asset value per share

 

30 November

2021

30 November

2020

31 May

2021

Income shares

 

 

 

Net asset value per share - pence

141.07p

127.16p

142.22p

Net assets attributable at end of

period - £'000

 

67,418

 

59,442

 

66,766

Shares in issue at end of period - number

47,792,165

46,744,790

46,944,790

 

 

 

 

Growth shares

 

 

 

Net asset value per share - pence

289.81p

249.94p

276.01p

Net assets attributable at end of

period - £'000

 

110,518

 

90,970

 

104,226

Shares in issue at end of period - number

38,135,148

36,396,553

37,761,553

 

 

 

 

 

 

10. Reconciliation of return on ordinary activities before tax to net cash flows from operating activities

 

 

Six months to 30 November 2021

 

Income shares

£'000

 

 Growth shares

£'000

 

Total

£'000

Return on ordinary activities before tax

Adjust for returns from non-operating activities:

1,093

 

5,224

6,317

Losses/(gains) on investments

18

(5,382)

(5,364)

Exchange losses

2

-

2

Return from operating activities

1,113

(158)

955

Decrease in prepayments

2

8

10

Decrease in creditors

(437)

(181)

(618)

Withholding tax recovered

(1)

-

(1)

Dividend income

(1,588)

(590)

(2,178)

Interest expense

70

-

70

Net cash outflow from operations before dividends and interest

 

(841)

 

(921)

 

(1,762)

     

 

 

 

 

Six months to 30 November 2020

 

Income shares

£'000

 

 Growth shares

£'000

 

Total

£'000

Return on ordinary activities before tax

Adjust for returns from non-operating activities:

6,870

 

15,006

21,876

Gains on investments

(5,794)

(15,079)

(20,873)

Exchange losses

13

-

13

Return from operating activities

1,089

(73)

1,016

Decrease in prepayments

5

5

10

Increase/(decrease) in creditors

112

(340)

(228)

Withholding tax recovered

37

-

37

Dividend income

(1,575)

(534)

(2,109)

Interest expense

55

-

55

Net cash outflow from operations before dividends and interest

 

(277)

 

(942)

 

(1,219)

     

 

 

 

 

Year to 31 May 2021

 

 

Income shares

£'000

 

 

Growth shares

£'000

 

 

Total

£'000

Return on ordinary activities before tax

Adjust for returns from non-operating activities:

15,229

 

24,553

39,782

Gains on investments

(13,297)

(24,835)

(38,132)

Exchange losses

17

-

17

Return from operating activities

1,949

(282)

1,667

Decrease/(increase) in prepayments

2

(7)

(5)

Increase/(decrease) in creditors

288

(84)

204

Withholding tax recovered

21

-

21

Dividend income

(2,981)

(1,040)

(4,021)

Interest income

(1)

-

(1)

Interest expense

116

-

116

Net cash outflow from operations before dividends and interest

 

(606)

 

(1,413)

 

(2,019)

     

 

 

 

 

11. Earnings

Earnings for the six months to 30 November 2021 should not be taken as a guide to the results for the full year to 31 May 2022.

 

12. Tax

The effective revenue tax rate for the period to 30 November 2021 is nil% (30 November 2020: nil%; 31 May 2021: 0.5%). This is lower than the rate of corporation tax for small companies due to the level of non-taxable dividend income.

 

13. Going concern

In assessing the going concern basis of accounting, the Directors have had regard to the guidance issued by the Financial Reporting Council (including that related to COVID-19) and have undertaken a rigorous review of the Company's ability to continue as a going concern and specifically in the context of the COVID-19 pandemic.

 

The Company's investment objective and policy, which is subject to regular Board monitoring processes, is designed to ensure that the Company is invested principally in listed securities. The value of these investments exceeds the Company's liabilities by a significant margin.

 

The Company retains title to all assets held by its custodian and has agreements relating to its borrowing facilities with which it has complied. Cash is only held with banks approved and regularly reviewed by the Manager.

 

The Directors believe, having assessed the principal risks and other matters, including the COVID-19 pandemic and in light of the controls and review processes and bearing in mind the nature of the Company's business and assets and revenue and expenditure projections, that the Company has adequate resources to continue in operational existence within its stated investment policy for a period of at least twelve months commencing from the date of approval of the financial statements. Accordingly, the financial statements have been drawn up on the basis that the Company is a going concern.

 

The Company does not have a fixed life. However, the Company's Articles of Association require the Board to put a resolution to shareholders at every fifth AGM to continue the Company. An ordinary resolution to approve the continuation of the Company was passed at the AGM held on 19 September 2018 and will next be put to shareholders at the AGM in 2023.

 

14. Related party transactions

The Directors of the Company are considered a related party. There have been no transactions with related parties during the first six months of the current financial year that have materially affected the financial position or performance of the Company during the period and there have been no changes in the related party transactions described in the last Annual Report that could do so.

 

15. Results

The Company's auditor, KPMG LLP, has not audited or reviewed the Interim Report to 30 November 2021 pursuant to the Auditing Practices Board guidance on 'Review of Interim Financial Information'. These are not full statutory financial statements in terms of Section 434 of the Companies Act 2006 and are unaudited. Statutory financial statements for the year ended 31 May 2021, which received an unqualified audit report, and which did not contain a statement under Section 498 of the Companies Act 2006, have been lodged with the Registrar of Companies. The abridged financial statements included for the year ended 31 May 2021 are an extract from those financial statements. No full statutory financial statements in respect of any period after 31 May 2021 have been reported on by the Company's auditor or delivered to the Registrar of Companies.

 

The Interim Report to 30 November 2021 is available on the website maintained on behalf of the Company at www.bmomanagedportfolio.com 

 

 

 

 

 

Statement of Principal Risks and Uncertainties

 

Most of the Company's principal risks and uncertainties that could threaten the achievement of its objective, strategy, future performance, liquidity and solvency are market related and comparable to those of other investment trusts investing primarily in listed securities.

 

These risks, and the way in which they are managed, are described in more detail under the heading ''Principal Risks and Uncertainties and Viability Statement" within the Strategic Report in the Company's Annual Report for the year ended 31 May 2021. The Company's principal risks and uncertainties have not changed materially since the date of that report and are not expected to change materially for the remainder of the Company's financial year.

 

The principal risks identified in the Annual Report were:

 

· Market Risk. The Company's assets consist mainly of listed closed-end investment companies and its principal financial risks are therefore market related and include market risk (comprising currency risk, interest rate risk and other price risk), liquidity risk and credit risk

· Investment Risk

· Custody Risk

· Operational Risk

 

These include risks in relation to failures at service providers or loss or sabotage of data through

cyber attacks or business continuity failure.

 

The Board has also considered the impact of the COVID-19 pandemic which has increased uncertainty and volatility in markets and has impacted the value of investments. In addition the operational resilience of the Manager and the Company's other third party service providers has been considered. This is included within market risk and operational risk.

 

Statement of Directors' Responsibilities in Respect of the Interim Report

 

We confirm, that to the best of our knowledge:

 

· the condensed set of financial statements have been prepared in accordance with applicable UK Accounting Standards on a going concern basis and give a true and fair view of the assets, liabilities, financial position and return of the Company;

 

· the Chairman's Statement and the Statement of Principal Risks and Uncertainties (together constituting the Interim Management Report) include a fair review of the information required by the Disclosure Guidance and Transparency Rule ('DTR') 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the financial statements;

 

· the Statement of Principal Risks and Uncertainties is a fair review of the principal risks and uncertainties for the remainder of the financial year; and

 

· the Interim Report includes a fair review of the information required by DTR 4.2.8R, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the Company during the period, and any changes in the related party transactions described in the last Annual Report that could do so.

 

 

On behalf of the Board

 

David Warnock

Director

24 January 2022

 

 

Alternative Performance Measures ("APMs")

The Company uses the following APMs:

Discount/premium - the share price of an investment company is derived from buyers and sellers trading their shares on the stock market. This price is not identical to the net asset value (NAV) per share of the underlying assets less liabilities of the Company. If the share price is lower than the NAV per share, the shares are trading at a discount. This usually indicates that there are more sellers of shares than buyers. Shares trading at a price above NAV per share are deemed to be at a premium usually indicating there are more buyers of shares than sellers.

 

 

 

30 November 2021

31 May 2021

 

 

Income shares

Growth shares

Income shares

Growth shares

 

 

 

 

 

 

Net asset value per share

(a)

141.07p

289.81p

142.22p

276.01p

Share price

(b)

144.00p

294.00p

143.50p

277.00p

Premium

(c=(b-a)/(a))

 

(c)

 

+2.1%

 

+1.4%

 

+0.9%

 

+0.4%

 

Total return - the return to shareholders calculated on a per share basis taking into account both any dividends paid in the period to the increase or decrease in the share price or NAV in the period. The dividends are assumed to have been re-invested in the form of shares or net assets, respectively, on the date on which the shares were quoted ex-dividend.

The effect of reinvesting these dividends on the respective ex-dividend dates and the share price total returns and NAV total returns are shown below.

 

 

Six months to

Year to

 

30 November 2021

31 May 2021

 

Income shares

Growth shares

Income shares

Growth shares

 

 

 

 

 

NAV per share at start of financial period/year

 

142.22p

 

276.01p

 

115.71p

 

208.35p

NAV per share at end of financial period/year

 

141.07p

 

289.81p

 

142.22p

 

276.01p

Change in the period/year

-0.8%

+5.0%

+22.9%

+32.5%

Impact of dividend reinvestment (1)

2.5%

n/a

6.1%

n/a

NAV total return for the period/year

+1.7%

+5.0%

+29.0%

+32.5%

 

 (1) During the six months to 30 November 2021 dividends totalling 3.55p went ex-dividend with respect to the Income shares. During the year to 31 May 2021 the equivalent figure was 6.2p.

 

 

 

Six months to 30 November 2021

Year to 31 May 2021

 

Income shares

Growth shares

Income shares

Growth shares

 

 

 

 

 

 

 

 

 

 

Share price per share at start of financial period/year

 

143.5p

 

277.0p

 

117.5p

 

212.0p

Share price per share at end of financial period/year

 

144.0p

 

294.0p

 

143.5p

 

277.0p

Change in the period/year

+0.3%

+6.1%

+22.1%

+30.7%

Impact of dividend reinvestment (1)

2.5%

n/a

6.1%

n/a

Share price total return for the period/year

 

+2.8%

 

+6.1%

 

+28.2%

 

+30.7%

 

(1) During the six months to 30 November 2021 dividends totalling 3.55p went ex-dividend with respect to the Income shares. During the year to 31 May 2021 the equivalent figure was 6.2p.

 

 

 

 

 

 

 

Yield - the total annual dividend expressed as a percentage of the period-end share price.

 

 

 

30 November 2021

31 May 2021

Annual dividend

(a)

6.2p(1)

6.2p

Income share price

(b)

144.0p

143.5p

Yield (c=a/b)

(c)

4.3%

4.3%

 

(1) Based on dividends at the expected minimum annual rate of 6.20 pence per Income share for the

financial year to 31 May 2022.

 

Net gearing/net cash - this is the ratio of the borrowings of the Company to its net assets. If the Company has cash assets, these may be assumed to net off against borrowings giving a "net" gearing percentage. Where cash assets exceed borrowings, the Company is described as having "net cash".

 

 

30 November 2021

31 May 2021

 

Income shares

Growth shares

Income shares

Growth shares

 

£'000

£'000

£'000

£'000

 

 

 

 

 

Borrowing

(7,000)

-

(7,000)

-

Cash

2,053

5,847

2,040

3,769

 

(4,947)

5,847

(4,960)

3,769

Net assets

67,418

110,518

66,766

104,226

 

-Net gearing/ +net cash

 

-7.3%

 

+5.3%

 

-7.4%

 

+3.6%

 

 

Compound annual growth rate - converts the total return over a period of more than one year to a constant annual rate of return applied to the compounded value at the start of each year.

 

30 November 2021

 

 

Income

shares

Growth

shares

Indexed NAV total return at 30 November 2011

 

100.0

100.0

Indexed NAV total return at 30 November 2021

 

245.5

314.0

Period (years)

 

10.0

10.0

Compound annual growth rate

 

9.4%

12.1%

 

 

 

 

For further information, please contact:

 

Peter Hewitt, BMO Investment Business Limited 0131 718 1244

Ian Ridge, BMO Investment Business Limited 0131 718 1010

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BRGDBGGDDGDS
Date   Source Headline
30th Jun 20221:54 pmRNSChange of Name
30th Jun 202212:50 pmRNSNet Asset Value(s)
29th Jun 202212:57 pmRNSNet Asset Value(s)
28th Jun 20221:05 pmRNSNet Asset Value(s)
27th Jun 20221:18 pmRNSNet Asset Value(s)
24th Jun 20221:27 pmRNSNet Asset Value(s)
23rd Jun 202212:51 pmRNSNet Asset Value(s)
22nd Jun 20224:59 pmRNSIssue of Equity
22nd Jun 20221:07 pmRNSNet Asset Value(s)
21st Jun 202212:55 pmRNSNet Asset Value(s)
20th Jun 20224:08 pmRNSNet Asset Value(s)
17th Jun 20222:37 pmRNSNet Asset Value(s)
16th Jun 20221:11 pmRNSNet Asset Value(s)
15th Jun 20221:05 pmRNSNet Asset Value(s)
14th Jun 20221:04 pmRNSNet Asset Value(s)
13th Jun 202212:54 pmRNSNet Asset Value(s)
10th Jun 20221:48 pmRNSNet Asset Value(s)
9th Jun 202212:55 pmRNSNet Asset Value(s)
9th Jun 202211:58 amRNSDirectorate Change
8th Jun 20224:53 pmRNSPortfolio Update
8th Jun 202212:56 pmRNSNet Asset Value(s)
7th Jun 20221:03 pmRNSNet Asset Value(s)
6th Jun 20222:09 pmRNSNet Asset Value(s)
6th Jun 202211:43 amRNSCompliance with Market Abuse Regulation
1st Jun 20221:15 pmRNSNet Asset Value(s)
31st May 202212:58 pmRNSNet Asset Value(s)
30th May 20221:44 pmRNSNet Asset Value(s)
27th May 202212:59 pmRNSNet Asset Value(s)
26th May 20222:47 pmRNSCancellation of Share Premium Account
26th May 202212:47 pmRNSNet Asset Value(s)
25th May 202212:52 pmRNSNet Asset Value(s)
24th May 20221:06 pmRNSNet Asset Value(s)
23rd May 20221:22 pmRNSNet Asset Value(s)
23rd May 202212:03 pmRNSInvestor Presentation
20th May 202212:56 pmRNSNet Asset Value(s)
19th May 20221:00 pmRNSNet Asset Value(s)
18th May 202212:52 pmRNSNet Asset Value(s)
17th May 20221:06 pmRNSNet Asset Value(s)
16th May 20221:07 pmRNSNet Asset Value(s)
13th May 20222:11 pmRNSPortfolio Update
13th May 20221:13 pmRNSNet Asset Value(s)
12th May 202212:51 pmRNSNet Asset Value(s)
11th May 202212:56 pmRNSNet Asset Value(s)
10th May 20221:04 pmRNSNet Asset Value(s)
9th May 20221:40 pmRNSNet Asset Value(s)
6th May 202212:42 pmRNSNet Asset Value(s)
5th May 202212:53 pmRNSNet Asset Value(s)
4th May 20221:00 pmRNSNet Asset Value(s)
3rd May 20223:49 pmRNSTotal Voting Rights
3rd May 20221:43 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.